Callan JMB (CJMB) announced that it has entered a preliminary agreement with the maker of an oral drug delivery system to install its innovative manufacturing equipment in Callan JMB’s cGMP facility in Texas, while the two companies negotiate operational agreements. “We are excited about this new partnership and the opportunities that installing the client’s manufacturing technology at our facility will open up for safe and effective oral drug delivery,” said Wayne Williams, CEO of Callan JMB. “This agreement is in line with our goals for expansion into ground-breaking healthcare and wellness technologies.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CJMB:
